FF/UMEC/VI Inhaler: Qualitative Analysis and Subject Preference Survey

CompletedOBSERVATIONAL
Enrollment

634

Participants

Timeline

Start Date

February 20, 2017

Primary Completion Date

February 23, 2018

Study Completion Date

February 23, 2018

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
OTHER

Telephone interviews

Qualitative concept elicitation telephone interviews will be conducted in subjects with COPD to explore treatment effectiveness, symptoms, quality of life, and features of treatment that are considered to be most important to them when making treatment choices.

OTHER

In-person focus groups

Qualitative concept elicitation in-person focus groups will be conducted in subjects with COPD to explore treatment effectiveness, symptoms, quality of life, and features of treatment that are considered to be most important to them when making treatment choices.

OTHER

DCE surveys- cognitive interviews

Draft version of the DCE surveys will be tested with subjects in cognitive interviews to explore the saliency of the attribute choices and assess whether the attributes are understandable, meaningful and comprehensive.

OTHER

Modified DCE

The modified DCEs will be piloted with subjects with COPD in each country to refine the underlying design and ensure that information is collected in an efficient way to enable the statistical analysis to be as precise as possible.

OTHER

Online DCE survey

An online DCE survey questionnaire will be given to the subjects to identify subject preferences, priorities and treatment goals.

Trial Locations (1)

EC4Y 0AY

GSK Investigational Site, London

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

ICON plc

INDUSTRY

lead

GlaxoSmithKline

INDUSTRY